How Information is Consumed

In this episode, Tom Caravela is joined by Andrew Fariello from AstraZeneca to explore the evolving landscape of Medical Science Liaisons (MSLs) in the context of data sharing and technological advancements. Andrew shares his career journey and insights into the growing importance of surveillance networks and real-world data, especially following the pandemic. The discussion delves into adapting MSL strategies to handle information overload while integrating patient perspectives into medical strategies. Andrew emphasizes the critical role of MSLs, highlighting advancements in engagement and innovative tools. The episode concludes with advice for MSLs navigating scientific developments and a call to action for listeners.

Today’s guest is Andrew Fariello, VP Global Medical Affairs, Head Medical Excellence, Oncology who discusses trends in information/data consumption and what MSLs can do for greater impact

We learn….

👉 How data is being shared as well as how it is being consumed
👉 What he means by the term “instantaneous Information”
👉 What role MSLs play in patient care and patient identification 
👉 How the MSL approach may need to change
👉 Areas of improvement for MSLs in KOL engagement

The podcast is available through the links below and anywhere podcasts can be found:

️ ️ 〰️ Spotify: https://lnkd.in/dRrSEyn

️ ️ 〰️ Apple: https://lnkd.in/egSthAz

️ ️ 〰️ Youtube: https://lnkd.in/dhaWVJU

MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversation and medical affairs discussions.

#msl #medicalaffairs #medicalscienceliaison #MSLTalk #pharmaceutical

(0:00) Introduction of Andrew Fariello from AstraZeneca
(0:19) Overview of the episode and reminders for listeners
(0:56) Andrew Fariello's background and career journey
(1:50) Sponsor: Aspire MSL program
(2:29) Evolution of data sharing and impact of the pandemic on MSL roles
(7:12) The growing importance of surveillance networks and real-world data
(9:07) Adapting MSL strategies to new data and technologies
(14:18) Addressing challenges in information overload and patient needs
(16:14) Integrating patient perspectives into medical strategies
(20:14) Advancements in MSL engagement and use of innovative tools
(24:41) Validating the critical role of MSLs in an evolving landscape
(26:50) Showcasing MSL team value and balancing engagement methods
(29:38) Navigating scientific developments and offering advice to MSLs
(32:04) Closing remarks and appreciation
(32:29) Outro and call to action for listeners